PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 400 Cypress Ave, South San Francisco,california 94080,united States
- to****@****vax.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- primevax.com
- Keywords
- Ottawa.
- HQ
- South San Francisco, California
Primevax Immuno-Oncology Questions
Primevax Immuno-Oncology's website is primevax.com
Primevax Immuno-Oncology's LinkedIn profile is https://www.linkedin.com/company/primevax
Primevax Immuno-Oncology has
7 employees.
View email and phone details for 7
employees at Primevax Immuno-Oncology.
Primevax Immuno-Oncology's industry is
Biotechnology Research
Primevax Immuno-Oncology's top competitors are
Keyops,
Rxfood Corporation,
Ignite Tournaments,
Careteam Technologies,
Akrivia Biomedics Limited,
Difinity Solutions,
Rehabtronics,
Cleanslate Uv,
Orion Biotechnology,
Neurovine.
Primevax Immuno-Oncology's support email address is tony.chen@primevax.com
Primevax Immuno-Oncology's categories are Biotechnology Research
Primevax Immuno-Oncology's founding year is 2015
